|| Securities, Unissued Securities
|| Price on Application
|| AUD A$3.5M raise at A$0.05 per share - A$2.75M already raised (pre-money valuation of A$1.57M)
Unlisted Australian company founded by Australian Nobel Laureate to develop and commercialise novel treatments in rapidly growing international market
for allergic indications including childhood eczema, food allergies, allergic asthma. Funds required to complete pre-clinical studies and quality manufacture
of patented product for use in animal safety studies and clinical trials.
Share this Listing